LANSOPRAZOLE | N020406 | TAKEDA PHARMACEUTICALS USA INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D.N.J. | 2018-07-18 | Terminated 2021-08-18 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Perrigo Company - Citizen Petition FDA-2011-P-0840 · 4 docket documents Perrigo Company filed this citizen petition pursuant to section 505(q) of the Federal Food, Drug, and Cosmetic Act requesting that FDA refuse to receive or rescind receipt of any ANDA for a generic version of Prevacid 24HR (lansoprazole) 15 mg capsules approved under NDA 022327 for OTC use if such A | 505(q) | 2011-11-25 | Denied | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$13.22
per ea
Lowest NADAC/Unit
$13.22
per ea
Brand NDCs
1
Generic NDCs
0
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 64764004613PREVACID DR 30 MG CAPSULE | $13.22 | EA | Brand | $0.1067 | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.